OTCMKTS:NMRD - Nemaura Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.26 +0.13 (+6.10 %)
(As of 10/23/2018 09:36 AM ET)
Previous Close$2.13
Today's Range$2.0201 - $2.3194
52-Week Range$1.93 - $6.80
Volume76,338 shs
Average Volume61,102 shs
Market Capitalization$362.07 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.4
Nemaura Medical, Inc. is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company's focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source. CGM through a non-invasive patch can enable early detection of subtle changes in blood glucose levels. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a CGM, named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes, and may also be used to screen pre-diabetic patients. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm.

Receive NMRD News and Ratings via Email

Sign-up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolOTCMKTS:NMRD
CUSIPN/A
Phone+44-1509-222912

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on Equity-31.25%
Return on Assets-21.89%

Miscellaneous

EmployeesN/A
Outstanding Shares205,000,000
Market Cap$362.07 million

Nemaura Medical (OTCMKTS:NMRD) Frequently Asked Questions

What is Nemaura Medical's stock symbol?

Nemaura Medical trades on the OTCMKTS under the ticker symbol "NMRD."

How were Nemaura Medical's earnings last quarter?

Nemaura Medical Inc (OTCMKTS:NMRD) released its quarterly earnings results on Thursday, August, 9th. The company reported ($0.01) EPS for the quarter. View Nemaura Medical's Earnings History.

Who are Nemaura Medical's key executives?

Nemaura Medical's management team includes the folowing people:
  • Dewan Fazlul Hoque Chowdhury, Chairman of the Board, President, Chief Executive Officer (Age 42)
  • Iain Anderson, Chief Financial Officer
  • Karrar Khan, Director of Product Development (Age 79)
  • David Scott, Director of Commercial Development and Licensing (Age 64)
  • Richard Toon, Business and Technical Development Manager (Age 45)
  • Bashir Timol, Director (Age 40)
  • Timothy Johnson, Independent Director
  • Thomas Moore, Independent Director
  • Salim Natha, Independent Director

How do I buy shares of Nemaura Medical?

Shares of NMRD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nemaura Medical's stock price today?

One share of NMRD stock can currently be purchased for approximately $2.26.

How big of a company is Nemaura Medical?

Nemaura Medical has a market capitalization of $362.07 million.

What is Nemaura Medical's official website?

The official website for Nemaura Medical is http://www.nemauramedical.com/.

How can I contact Nemaura Medical?

Nemaura Medical's mailing address is Advanced Technology Innovation Centre Loughborough Univ Science & Enterprise, LOUGHBOROUGH, LE11 3QF, United Kingdom. The company can be reached via phone at +44-1509-222912.


MarketBeat Community Rating for Nemaura Medical (OTCMKTS NMRD)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  24 (Vote Outperform)
Underperform Votes:  18 (Vote Underperform)
Total Votes:  42
MarketBeat's community ratings are surveys of what our community members think about Nemaura Medical and other stocks. Vote "Outperform" if you believe NMRD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NMRD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/23/2018 by MarketBeat.com Staff

Featured Article: Hedge Funds Explained

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel